Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy

scientific article

Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JHEP.2015.06.021
P932PMC publication ID4615530
P698PubMed publication ID26143441
P5875ResearchGate publication ID279754010

P2093author name stringAnthony J Scarzello
Jimmy K Stauffer
Jonathan M Weiss
Robert H Wiltrout
Qun Jiang
W Gregory Alvord
Jeff J Subleski
Bahara Saleh
Timothy Back
Anthony Kronfli
P2860cites workCoactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumorsQ24620075
Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injectionQ24646028
Viral immune evasion due to persistence of activated T cells without effector functionQ24646943
Cancer statistics, 2010Q27860525
Molecular mechanisms of cancer development in obesityQ28253823
Hepatocellular carcinoma: epidemiology and molecular carcinogenesisQ28306363
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalenceQ29616009
The immunobiology of cancer immunosurveillance and immunoeditingQ29616246
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013Q29616834
Angiogenesis as a therapeutic targetQ29619525
High-resolution characterization of a hepatocellular carcinoma genomeQ31005512
Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer driversQ34323801
Viral hepatitis and liver cancer: the case of hepatitis C.Q34568619
Does the immune system see tumors as foreign or self?Q35077428
CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.Q35783166
Three-dimensional multispecies nonlinear tumor growth--I Model and numerical methodQ36321568
TCR-dependent and -independent activation underlie liver-specific regulation of NKT cellsQ37051132
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinomaQ37284612
c-MET as a potential therapeutic target and biomarker in cancerQ37962905
Hydrodynamic transfection for generation of novel mouse models for liver cancer researchQ38183539
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumorsQ39089944
Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamstersQ40188613
Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytesQ40550055
T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patientsQ45876112
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemiaQ45882160
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.Q53206297
Liver diseases in Thailand. An analysis of liver biopsiesQ72828282
Molecular pathogenesis of human hepatocellular carcinomaQ74543031
Three-dimensional movement of a liver tumor detected by high-speed magnetic resonance imagingQ77958073
Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liverQ79362790
P433issue5
P921main subjectliver cancerQ623031
P304page(s)1181-1189
P577publication date2015-07-01
P1433published inJournal of HepatologyQ15724402
P1476titleSerum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy
P478volume63

Reverse relations

cites work (P2860)
Q388072581001 lights: luciferins, luciferases, their mechanisms of action and applications in chemical analysis, biology and medicine
Q35926191Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model
Q64288110Extracellular Vesicle-Based Therapeutic Targeting of β-Catenin to Modulate Anticancer Immune Responses in Hepatocellular Cancer
Q36919260Imaging Tumor Vascularity and Response to Anti-Angiogenic Therapy Using Gaussia Luciferase
Q89108940Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research
Q33803540On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C

Search more.